THC Antibodies

Santa Cruz Biotechnology offers a broad range of THC Antibodies for the specific detection and analysis of tetrahydrocannabinol (THC) in research applications. THC Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Tetrahydrocannabinol is the primary psychoactive component of cannabis, playing a crucial role in the modulation of various physiological processes, including pain sensation, mood regulation, and appetite control. Understanding THC's interactions and effects is essential for advancing research in pharmacology, neuroscience, and therapeutic applications. THC research has revealed significant insights into cannabinoid receptor signaling pathways and their influence on neural function. Investigating THC mechanisms has enhanced our knowledge of endocannabinoid system regulation and its therapeutic potential. Recent studies have highlighted THC's complex interactions with various cellular pathways and neurotransmitter systems. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing cannabis-related scientific discoveries and therapeutic developments.